Biogen Whistleblower's $250M Award 'Extraordinary' For FCA
By Jeff Overley · September 27, 2022, 10:33 PM EDT
A former pharmaceutical manager's $250 million cut of Biogen's $900 million payments-for-prescriptions settlement is among the largest whistleblower awards in U.S. history, delivering a shot of adrenaline to other False Claims...
To view the full article, register now.